Search
Showing results for "Childhood interstitial lung disease "
A testimonial about Jean Golding's achievements in paediatric epidemiology.
We wanted to embark on an epidemiological research project that would contribute new knowledge and, at the same time, might prove the value of the registry...
Fetal head circumference (HC) growth was examined prospectively in children with autism spectrum disorder (ASD).
An open letter to politicians on climate change and obesity
Improving the wellbeing of Australian children and youth: the importance of bridging the know-do gap
Data for recent years show a shift away from a classification of 'SIDS' towards a classification of 'unascertainable', particularly for Aboriginal infants.
A world-first study involving more than 100 cancer researchers and clinicians across Australia – including from The Kids Research Institute Australia and Perth Children’s Hospital – has shown that precision medicine can significantly improve outcomes for children with high-risk cancer.
Find out about our approach to procurement, what we procure and how to become a Supply Partner.
Vancomycin is first-line treatment for methicillin-resistant Staphylococcus aureus infections. However, despite guideline recommendations, there is no evidence that targeting vancomycin trough concentrations of ≥15 mg/L in children confers clinical benefit and is associated with vancomycin-associated nephrotoxicity.
Congenital cytomegalovirus (cCMV) is an important cause of long-term childhood disability. In Australia, the identification and treatment practices and the long-term clinical and neurodevelopmental outcomes of children with cCMV are unknown.